T1	CHEM 13 19	calcio
#1	AnnotatorNotes T1	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T2	CHEM 25 35	vitamina D
#2	AnnotatorNotes T2	C0042866; vitamin D; Pharmacologic Substance · Hormone · Vitamin
T3	CHEM 46 55	lactulosa
#3	AnnotatorNotes T3	C0022957; lactulose; Organic Chemical · Pharmacologic Substance
T4	DISO 116 126	osteopenia
#4	AnnotatorNotes T4	C0029453; Osteopenia; Disease or Syndrome
T5	PROC 128 167	Ensayo piloto controlado y aleatorizado
#5	AnnotatorNotes T5	C0031928; Pilot Projects; Research Activity + C0206035; Controlled Clinical Trials, Randomized; Research Activity
T6	PROC 1504 1507	DMO
#6	AnnotatorNotes T6	C0177804; Bone Mineral Density Test; Diagnostic Procedure
T7	CHEM 186 195	lactulosa
#7	AnnotatorNotes T7	C0022957; lactulose; Organic Chemical · Pharmacologic Substance
T8	CHEM 202 215	oligosacárido
#8	AnnotatorNotes T8	C0028959; Oligosaccharides; Organic Chemical
T9	CHEM 243 250	laxante
#9	AnnotatorNotes T9	C0282090; Laxatives; Pharmacologic Substance
T10	CHEM 324 330	calcio
#10	AnnotatorNotes T10	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T11	PROC 1571 1574	DMO
#11	AnnotatorNotes T11	C0177804; Bone Mineral Density Test; Diagnostic Procedure
T12	CHEM 462 468	calcio
#12	AnnotatorNotes T12	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T13	DISO 483 502	efectos secundarios
#13	AnnotatorNotes T13	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T14	PROC 1959 1962	DMO
#14	AnnotatorNotes T14	C0177804; Bone Mineral Density Test; Diagnostic Procedure
T15	PROC 550 623	estudio piloto aleatorizado, doble ciego, doble simulación, multicéntrico
T16	PHYS 95 111	postmenopáusicas
#15	AnnotatorNotes T16	C0206159; Postmenopause; Organism Function
T17	CHEM 668 677	lactulosa
#16	AnnotatorNotes T17	C0022957; lactulose; Organic Chemical · Pharmacologic Substance
T18	CHEM 690 696	calcio
#17	AnnotatorNotes T18	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T19	PHYS 801 817	postmenopáusicas
#18	AnnotatorNotes T19	C0206159; Postmenopause; Organism Function
T20	CHEM 709 719	vitamina D
#19	AnnotatorNotes T20	C0042866; vitamin D; Pharmacologic Substance · Hormone · Vitamin
T21	DISO 822 832	osteopenia
#20	AnnotatorNotes T21	C0029453; Osteopenia; Disease or Syndrome
T22	CHEM 870 876	calcio
#21	AnnotatorNotes T22	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T23	PHYS 1974 1990	postmenopáusicas
#22	AnnotatorNotes T23	C0206159; Postmenopause; Organism Function
T24	CHEM 960 969	lactulosa
#23	AnnotatorNotes T24	C0022957; lactulose; Organic Chemical · Pharmacologic Substance
T25	CHEM 998 1007	lactulosa
#24	AnnotatorNotes T25	C0022957; lactulose; Organic Chemical · Pharmacologic Substance
T26	CHEM 1047 1058	vitamina D3
#25	AnnotatorNotes T26	C0008318; cholecalciferol; Organic Chemical · Pharmacologic Substance · Vitamin | C3265062; vitamin D3; Organic Chemical · Pharmacologic Substance · Vitamin
T27	CHEM 1075 1094	carbonato de calcio
#26	AnnotatorNotes T27	C0006681; calcium carbonate; Pharmacologic Substance · Inorganic Chemical
T28	PROC 1111 1118	placebo
#27	AnnotatorNotes T28	C0032042; Placebos; Therapeutic or Preventive Procedure
T29	PROC 1167 1174	placebo
#28	AnnotatorNotes T29	C0032042; Placebos; Therapeutic or Preventive Procedure
T30	CHEM 1200 1209	lactulosa
#29	AnnotatorNotes T30	C0022957; lactulose; Organic Chemical · Pharmacologic Substance
T31	PROC 1210 1217	placebo
#30	AnnotatorNotes T31	C0032042; Placebos; Therapeutic or Preventive Procedure
T32	CHEM 1233 1244	vitamina D3
#31	AnnotatorNotes T32	C0008318; cholecalciferol; Organic Chemical · Pharmacologic Substance · Vitamin | C3265062; vitamin D3; Organic Chemical · Pharmacologic Substance · Vitamin
T33	CHEM 1263 1282	carbonato de calcio
#32	AnnotatorNotes T33	C0006681; calcium carbonate; Pharmacologic Substance · Inorganic Chemical
T34	CHEM 1330 1336	calcio
#33	AnnotatorNotes T34	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T35	CHEM 1596 1605	lactulosa
#34	AnnotatorNotes T35	C0022957; lactulose; Organic Chemical · Pharmacologic Substance
T36	PROC 1615 1622	placebo
#35	AnnotatorNotes T36	C0032042; Placebos; Therapeutic or Preventive Procedure
T37	PROC 1693 1702	protocolo
#36	AnnotatorNotes T37	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T38	PROC 1759 1791	análisis por intención de tratar
#37	AnnotatorNotes T38	C2718028; Intention to Treat Analysis; Research Activity
T39	PROC 1882 1896	estudio piloto
#38	AnnotatorNotes T39	C0031928; Pilot Projects; Research Activity
T40	PROC 2024 2035	tratamiento
#39	AnnotatorNotes T40	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T41	CHEM 2076 2082	calcio
#40	AnnotatorNotes T41	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T42	CHEM 2085 2095	vitamina D
#41	AnnotatorNotes T42	C0042866; vitamin D; Pharmacologic Substance · Hormone · Vitamin
T43	ANAT 79 83	ósea
#42	AnnotatorNotes T43	C0262950; Skeletal bone; Body Part, Organ, or Organ Component | C0391978; Bone Tissue; Tissue
T44	ANAT 310 320	intestinal
#43	AnnotatorNotes T44	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T45	ANAT 407 411	ósea
#44	AnnotatorNotes T45	C0262950; Skeletal bone; Body Part, Organ, or Organ Component | C0391978; Bone Tissue; Tissue
T46	ANAT 779 783	ósea
#45	AnnotatorNotes T46	C0262950; Skeletal bone; Body Part, Organ, or Organ Component | C0391978; Bone Tissue; Tissue
T47	CHEM 902 912	vitamina D
#46	AnnotatorNotes T47	C0042866; vitamin D; Pharmacologic Substance · Hormone · Vitamin
T48	CHEM 1122 1128	calcio
#47	AnnotatorNotes T48	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T49	ANAT 2005 2009	ósea
#48	AnnotatorNotes T49	C0262950; Skeletal bone; Body Part, Organ, or Organ Component | C0391978; Bone Tissue; Tissue
T50	CHEM 2040 2049	lactulosa
#49	AnnotatorNotes T50	C0022957; lactulose; Organic Chemical · Pharmacologic Substance
T51	Neg_cue 42 45	sin
T53	LIVB 87 94	mujeres
#50	AnnotatorNotes T53	C0043210; Woman; Population Group
T55	PHYS 300 320	absorción intestinal
#51	AnnotatorNotes T55	C0021826; Intestinal Absorption; Organ or Tissue Function
T58	Neg_cue 470 478	evitando
T60	Dose 680 686	500 mg
T61	Dose 699 705	400 UI
T62	Duration 728 736	12 meses
T65	LIVB 793 800	mujeres
#52	AnnotatorNotes T65	C0043210; Woman; Population Group
T67	Dose 854 862	1.000 mg
T68	Frequency 862 866	/día
T69	LIVB 939 946	mujeres
#53	AnnotatorNotes T69	C0043210; Woman; Population Group
T70	Dose 985 990	15 mL
T71	Frequency 990 994	/día
T72	Dose 1023 1030	10,05 g
T73	Dose 1033 1039	400 UI
T74	Frequency 1039 1043	/día
T75	Dose 1061 1067	500 mg
T76	Frequency 1067 1071	/día
T77	Dose 1097 1103	500 mg
T78	Frequency 1103 1107	/día
T79	LIVB 1149 1156	mujeres
#54	AnnotatorNotes T79	C0043210; Woman; Population Group
T80	Dose 1219 1225	400 UI
T81	Frequency 1225 1229	/día
T82	Dose 1247 1255	1.000 mg
T83	Frequency 1255 1259	/día
T84	Frequency 1320 1326	diaria
T90	LIVB 1966 1973	mujeres
#55	AnnotatorNotes T90	C0043210; Woman; Population Group
T93	Duration 2015 2020	1 año
T94	Dose 2061 2072	dosis bajas
#56	AnnotatorNotes T94	C0445550; Low dose; Quantitative Concept
T52	PHYS 1312 1319	ingesta
#57	AnnotatorNotes T52	C0232478; Ingestion; Biologic Function
T54	PROC 762 783	densidad mineral ósea
#58	AnnotatorNotes T54	C0177804; Bone Mineral Density Test; Diagnostic Procedure
T56	PROC 785 788	DMO
#59	AnnotatorNotes T56	C0177804; Bone Mineral Density Test; Diagnostic Procedure
T57	PROC 62 83	densidad mineral ósea
#60	AnnotatorNotes T57	C0177804; Bone Mineral Density Test; Diagnostic Procedure
T59	DISO 1995 2009	baja masa ósea
#61	AnnotatorNotes T59	C0029453; Osteopenia; Disease or Syndrome
T63	PROC 430 447	reducir las dosis
#62	AnnotatorNotes T63	C2348004; Agent Dose Decreased; Therapeutic or Preventive Procedure
T64	Spec_cue 414 420	podría
A1	Assertion T13 Negated
A2	Assertion T3 Negated
A3	Assertion T63 Speculated
T66	Quantifier_or_Qualifier 1633 1664	estadísticamente significativas
A4	Assertion T66 Negated
#63	AnnotatorNotes T66	C0237881; Statistical Significance; Quantitative Concept
T85	Neg_cue 1623 1625	no
R1	Negation Arg1:T85 Arg2:T66	
R2	Negation Arg1:T51 Arg2:T3	
T86	Spec_cue 343 364	potencialmente podría
T87	Observation 374 392	efecto beneficioso
A5	Assertion T87 Speculated
#64	AnnotatorNotes T87	C4049461; Unexpected beneficial therapeutic response; Finding (?)
T88	LIVB 1517 1534	grupos de estudio
#65	AnnotatorNotes T88	C2348561; Study Population (group); Population Group
T89	Observation 1 8	Efectos
#66	AnnotatorNotes T89	C1518681; Outcome of Therapy; Finding (?)
R3	Causes Arg1:T1 Arg2:T89	
R4	Causes Arg1:T2 Arg2:T89	
R5	Location_of Arg1:T43 Arg2:T57	
R6	Experiences Arg1:T53 Arg2:T89	
R7	Experiences Arg1:T53 Arg2:T4	
R8	Experiences Arg1:T53 Arg2:T16	
R9	Combined_with Arg1:T1 Arg2:T2	
R10	Combined_with Arg1:T2 Arg2:T3	
R11	Overlap Arg1:T16 Arg2:T4	
R12	Experiences Arg1:T53 Arg2:T57	
R13	Causes Arg1:T7 Arg2:T55	
R14	Location_of Arg1:T44 Arg2:T55	
R15	Used_for Arg1:T10 Arg2:T55	
R16	Before Arg1:T7 Arg2:T87	
R17	Speculation Arg1:T86 Arg2:T87	
R18	Location_of Arg1:T45 Arg2:T87	
R19	Speculation Arg1:T64 Arg2:T63	
R20	Used_for Arg1:T12 Arg2:T63	
R21	Negation Arg1:T58 Arg2:T13	
R22	Causes Arg1:T12 Arg2:T13	
R23	Before Arg1:T7 Arg2:T63	
R24	Has_Dose_or_Strength Arg1:T17 Arg2:T60	
R25	Combined_with Arg1:T17 Arg2:T18	
R26	Combined_with Arg1:T18 Arg2:T20	
R27	Has_Dose_or_Strength Arg1:T18 Arg2:T61	
R28	Has_Duration_or_Interval Arg1:T20 Arg2:T62	
R29	Has_Duration_or_Interval Arg1:T18 Arg2:T62	
R30	Has_Duration_or_Interval Arg1:T17 Arg2:T62	
R31	Experiences Arg1:T65 Arg2:T54	
R32	Experiences Arg1:T65 Arg2:T56	
R33	Location_of Arg1:T46 Arg2:T54	
R34	Location_of Arg1:T46 Arg2:T56	
R35	Experiences Arg1:T65 Arg2:T19	
R36	Overlap Arg1:T19 Arg2:T21	
R37	Experiences Arg1:T65 Arg2:T21	
R38	Experiences Arg1:T65 Arg2:T17	
R48	Combined_with Arg1:T22 Arg2:T91	
R49	Has_Frequency Arg1:T22 Arg2:T68	
R50	Has_Dose_or_Strength Arg1:T22 Arg2:T67	
R51	Experiences Arg1:T65 Arg2:T22	
T91	Food 888 898	suplemento
#67	AnnotatorNotes T91	C0242295; Dietary Supplements; Food
R52	Combined_with Arg1:T91 Arg2:T47	
R53	Experiences Arg1:T69 Arg2:T24	
R54	Has_Dose_or_Strength Arg1:T24 Arg2:T70	
R55	Has_Frequency Arg1:T24 Arg2:T71	
R56	Has_Frequency Arg1:T25 Arg2:T71	
R57	Has_Dose_or_Strength Arg1:T25 Arg2:T70	
R58	Has_Dose_or_Strength Arg1:T25 Arg2:T72	
R59	Combined_with Arg1:T25 Arg2:T26	
R60	Combined_with Arg1:T24 Arg2:T26	
R61	Combined_with Arg1:T26 Arg2:T27	
R62	Combined_with Arg1:T27 Arg2:T28	
R63	Used_for Arg1:T48 Arg2:T28	
R64	Has_Frequency Arg1:T48 Arg2:T78	
R65	Has_Dose_or_Strength Arg1:T48 Arg2:T77	
R66	Has_Dose_or_Strength Arg1:T26 Arg2:T73	
R67	Has_Frequency Arg1:T26 Arg2:T74	
R68	Has_Frequency Arg1:T27 Arg2:T76	
R69	Has_Dose_or_Strength Arg1:T27 Arg2:T75	
R70	Experiences Arg1:T79 Arg2:T29	
R71	Used_for Arg1:T30 Arg2:T31	
R72	Used_for Arg1:T30 Arg2:T29	
R73	Combined_with Arg1:T30 Arg2:T32	
R74	Combined_with Arg1:T32 Arg2:T33	
R75	Has_Frequency Arg1:T33 Arg2:T83	
R76	Has_Dose_or_Strength Arg1:T33 Arg2:T82	
R77	Has_Frequency Arg1:T32 Arg2:T81	
R78	Has_Dose_or_Strength Arg1:T32 Arg2:T80	
R79	Used_for Arg1:T34 Arg2:T52	
R80	Has_Frequency Arg1:T34 Arg2:T84	
T92	CONC 1403 1419	regresión lineal
R81	Experiences Arg1:T88 Arg2:T6	
T95	CONC 1553 1564	diferencias
#68	AnnotatorNotes T95	C1705241; Delta (difference); Quantitative Concept
R82	Has_Quantifier_or_Qualifier Arg1:T95 Arg2:T66	
R83	Experiences Arg1:T90 Arg2:T14	
R84	Experiences Arg1:T90 Arg2:T23	
R85	Overlap Arg1:T23 Arg2:T59	
R86	Location_of Arg1:T49 Arg2:T59	
R87	Has_Duration_or_Interval Arg1:T40 Arg2:T93	
R88	Experiences Arg1:T90 Arg2:T40	
R89	After Arg1:T59 Arg2:T93	
R91	Used_for Arg1:T50 Arg2:T40	
R92	Combined_with Arg1:T50 Arg2:T41	
R93	Has_Dose_or_Strength Arg1:T41 Arg2:T94	
R94	Has_Dose_or_Strength Arg1:T42 Arg2:T94	
R95	Combined_with Arg1:T41 Arg2:T42	
#70	AnnotatorNotes T92	C0023733; Linear Regression; Quantitative Concept
T96	CONC 1480 1497	valores iniciales
#69	AnnotatorNotes T96	C1442488; Baseline; Quantitative Concept
T97	Spec_cue 651 653	si
T98	CONC 750 758	mantener
A6	Assertion T98 Speculated
R39	Speculation Arg1:T97 Arg2:T98	
A7	Experiencer T90 Patient
A8	Experiencer T53 Patient
A9	Experiencer T65 Patient
A10	Experiencer T69 Patient
A11	Experiencer T88 Patient
A12	Experiencer T79 Patient
